Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
NTRA

NTRA - Natera Inc Stock Price, Fair Value and News

$235.85-4.49 (-1.87%)
Market Closed

36/100

NTRA

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

36/100

NTRA

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$193.26

Target 3M

$225.88

Target 6M

$211.14

NTRA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NTRA Price Action

Last 7 days

-2.8%

Last 30 days

2.0%

Last 90 days

22.1%

Trailing 12 Months

40.3%

NTRA RSI Chart

NTRA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NTRA Valuation

Market Cap

32.6B

Price/Earnings (Trailing)

-105.28

Price/Sales (Trailing)

15.38

EV/EBITDA

-117.42

Price/Free Cashflow

306.89

NTRA Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$193.26

Target 3M

$225.88

Target 6M

$211.14

NTRA Fundamentals

NTRA Revenue

Revenue (TTM)

2.1B

Rev. Growth (Yr)

34.66%

Rev. Growth (Qtr)

8.34%

NTRA Earnings

Earnings (TTM)

-309.2M

Earnings Growth (Yr)

-177.11%

Earnings Growth (Qtr)

13.27%

NTRA Profitability

EBT Margin

-14.64%

Return on Equity

-24.69%

Return on Assets

-16.97%

Free Cashflow Yield

0.33%

NTRA Investor Care

Shares Dilution (1Y)

4.54%

Diluted EPS (TTM)

-2.29

NTRA Alerts

  • 6 major insider sales recently.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20251.8B2.0B2.1B0
20241.2B1.4B1.5B1.7B
2023867.8M931.0M988.7M1.1B
2022667.3M723.5M776.0M820.2M
2021449.3M504.9M564.8M625.5M
2020329.5M341.6M361.9M391.0M
2019262.1M273.4M286.1M302.3M
2018222.6M233.4M242.7M257.7M
2017204.6M204.9M206.9M209.6M
2016204.8M211.7M220.7M217.1M
2015179.4M188.7M187.3M190.4M
201481.2M107.2M133.3M159.3M
201300055.2M
Get all data in R, Python etc through our Historical Stock Data APIs

About Natera Inc

NTRA
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company's products also comprise Signatera, a ctDNA blood test for molecular residual disease assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based comprehensive genomic profiling test; Prospera to assess active rejection in patients who have undergone kidney transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests. The company offers products through its direct sales force, as well as through a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was founded in 2003 and is headquartered in Austin, Texas.
 CEO
 WEBSITEnatera.com
 SECTORHealthcare
 INDUSTRYDiagnostics & Research
 EMPLOYEES2958

Natera Inc Frequently Asked Questions

NTRA is the stock ticker symbol of Natera Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Natera Inc is 32.55 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check NTRA's fair value in chart for subscribers.

The fair value guage provides a quick view whether NTRA is over valued or under valued. Whether Natera Inc is cheap or expensive depends on the assumptions which impact Natera Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NTRA.

As of Wed Jan 28 2026, NTRA's PE ratio (Price to Earnings) is -105.28 and Price to Sales (PS) ratio is 15.38. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NTRA PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Natera Inc has provided 0.393 (multiply by 100 for percentage) rate of return.